Opthea Limited American Depositary Shares (OPT)
Company News
SpyGlass Pharma appointed Anand Sundaram as Vice President, Head of Commercial, bringing over a decade of commercial launch experience in ophthalmic treatments to help advance their Drug Delivery Platform into Phase III trials.
Several ASX-listed companies saw their shares rise significantly on Monday, including Atturra, Bravura Solutions, Core Lithium, and Opthea. The gains were driven by various factors, such as acquisition agreements, positive guidance updates, and successful capital raises.
Shares of Netflix, Inc. (NASDAQ: NFLX) shares rose sharply in today’s pre-market trading as the company reported better-than-expected sales for its fourth quarter. Netflix reported fourth-quarter revenue of $8.83 billion, which was up 12.5% year-over-year. The total came in ahead of a Street consensus estimate of $8.72 billion. The company reported fourth-quarter earnings per share of $2.11, which missed a Street consensus estimate of $2.21. The company, meanwhile, added 13.12 million net paid subscribers in the fourth quarter. Netflix shares jumped 10.2% to $542.48 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers Getaround, Inc. (NYSE: GETR) gained 50.7% to $0.2771 in pre-market trading after the company announced a new debt facility with Mudrick Capital Management for up to $20 million. Evaxion Biotech A/S (NASDAQ: EVAX) gained 43.2% to $7.15 in pre-market trading after a 13G filing showed Merck & Co reported an 11.4% stake in the company as of December 21, 2023. VS MEDIA Holdings Limited (NASDAQ: VSME) shares jumped 31.7% to $0.4318 in ...